Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18095113rdf:typepubmed:Citationlld:pubmed
pubmed-article:18095113lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:18095113lifeskim:mentionsumls-concept:C0079427lld:lifeskim
pubmed-article:18095113lifeskim:mentionsumls-concept:C0033375lld:lifeskim
pubmed-article:18095113lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:18095113lifeskim:mentionsumls-concept:C0040690lld:lifeskim
pubmed-article:18095113lifeskim:mentionsumls-concept:C0919432lld:lifeskim
pubmed-article:18095113lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:18095113pubmed:issue1lld:pubmed
pubmed-article:18095113pubmed:dateCreated2007-12-20lld:pubmed
pubmed-article:18095113pubmed:abstractTextThe presence of transforming growth factor-beta receptor type II and Smad3 gene abnormality was examined in human prolactinomas by single-strand conformation polymorphism screening for gene abnormality and band shift in tumor tissue and peripheral blood samples obtained from 14 patients treated for prolactinoma. Direct sequencing of exon 4 of the transforming growth factor-beta receptor type II gene, which showed a band shift by single-strand conformation polymorphism, disclosed a single nucleotide polymorphism (rs2228048) (alleles A/G; average allele frequency, G:0.817, A:0.183) and not an active mutation. Seven of the 14 cases showed base substitution (G --> A) of the single nucleotide polymorphism. Two of these 7 cases showed base substitution (G --> A) in the blood sample in accordance with neoplastic transformation. Direct sequencing of exon 2 of the Smad3 gene, which showed band shift by single-strand conformation polymorphism, disclosed single nucleotide polymorphism (rs1065080) (alleles C/T; average allele frequency, C:0.947, T:0.053) and no active mutation. Four of the 14 cases showed base substitution (C --> T) of the single nucleotide polymorphism. Blood samples were available for 2 of these 4 cases, and 1 of these 2 cases showed base substitution (C --> T) in accordance with neoplastic transformation. Estimation of the drug sensitivity of pituitary adenoma based on analysis of peripheral blood cells needs special care.lld:pubmed
pubmed-article:18095113pubmed:languageenglld:pubmed
pubmed-article:18095113pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18095113pubmed:citationSubsetIMlld:pubmed
pubmed-article:18095113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18095113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18095113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18095113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18095113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18095113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18095113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18095113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18095113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18095113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18095113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18095113pubmed:statusMEDLINElld:pubmed
pubmed-article:18095113pubmed:monthAprlld:pubmed
pubmed-article:18095113pubmed:issn1433-7398lld:pubmed
pubmed-article:18095113pubmed:authorpubmed-author:IkedaHidetosh...lld:pubmed
pubmed-article:18095113pubmed:issnTypePrintlld:pubmed
pubmed-article:18095113pubmed:volume23lld:pubmed
pubmed-article:18095113pubmed:ownerNLMlld:pubmed
pubmed-article:18095113pubmed:authorsCompleteYlld:pubmed
pubmed-article:18095113pubmed:pagination7-12lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:meshHeadingpubmed-meshheading:18095113...lld:pubmed
pubmed-article:18095113pubmed:year2006lld:pubmed
pubmed-article:18095113pubmed:articleTitleMutational analysis of transforming growth factor-beta receptor type II and Smad3 tumor suppressor genes in prolactinomas.lld:pubmed
pubmed-article:18095113pubmed:affiliationDepartment of Neurosurgery, Kohnan Hospital, Sendai, Japan. ikeda@nsg.med.tohoku.ac.jplld:pubmed
pubmed-article:18095113pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18095113pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:4088entrezgene:pubmedpubmed-article:18095113lld:entrezgene
entrez-gene:7048entrezgene:pubmedpubmed-article:18095113lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18095113lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18095113lld:entrezgene